Volume of the amygdala is reduced in patients with narcolepsy - A structural MRI study

Neuroendocrinology Letters

Volumn 32, Issue 5, 2011, Pages 652-656

  Brabec, Jiří ^a   Rulseh, Aaron ^a   Hořínek, Daniel ^a,b   Pala, Andrej ^a   Guerreiro, Helena ^a   Bušková, Jitka ^c   Petrovický, Pavel ^a   Němcová, Veronika ^a   Krásenský, Jan ^c   Seidl, Zdeněk ^c   Nimsky, Christopher ^d   Šonka, Karel ^c  

^a CHARLES UNIVERSITY   (Czech Republic)

^b International Clinical Research Centre   (Czech Republic)

^c CHARLES UNIVERSITY   (Czech Republic)

^d PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

Amygdala; Cataplexy; MRI volumetry; Narcolepsy; Nucleus accumbens

Indexed keywords

OXYBATE SODIUM; PSYCHOSTIMULANT AGENT; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT;

ADULT; AMYGDALOID NUCLEUS; ANTERIOR COMMISSURE; ARTICLE; BRAIN MALFORMATION; BRAIN SIZE; CATAPLEXY; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE DURATION; FEMALE; HUMAN; HYPOTHALAMUS; MALE; NARCOLEPSY; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEUS ACCUMBENS;

EID: 84857436160     PISSN: 0172780X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. American Academy of Sleep Medicine (2005). International classification of sleep disorders, 2nd ed.: Diagnostic and coding manual, Wetchester (III): American Academy of Sleep Medicine
2. Bisetti A, Cvetkovic V, Serafin M, Bayer L, Machard D, Jones BE, et al. (2006) Excitatory action of hypocretin/orexin on neurons of the central medial amygdala. Neuroscience. 142: 999-1004. (Pubitemid 44636051)
3. Brabec J, Rulseh A, Hoyt B, Vizek M, Horinek D, Hort J, et al. (2010). Volumetry of the human amygdala- An anatomical study. Psychiatry Res. 182: 67-72.
4. Brenneis C, Brandauer E, Frauscher B, Schocke M, Trieb T, Poewe W, et al. (2005). Voxel-based morphometry in narcolepsy. Sleep Med. 6: 531-6. (Pubitemid 41671208)
5. Buskova J, Vaneckova M, Sonka K, Seidl Z, Nevsimalova S (2006). Reduced hypothalamic gray matter in narcolepsy with cataplexy. Neuro Endocrinol Lett. 27: 769-72. (Pubitemid 46138637)
6. Calvo JM, Simon-Arceo K, Fernandez-Mas R (1996). Prolonged enhancement of REM sleep produced by carbachol microinjection into the amygdala. NeuroReport. 7: 577-80. (Pubitemid 26105044)
7. Crum WR, Griffin LD, Hill DL, Hawkes DJ (2003). Zen and the art of medical image registration: correspondence, homology, and quality. Neuroimage. 20:1425-37. (Pubitemid 37468253)
8. Davatzikos C, Genc A, Xu D, Resnick SM (2001). Voxel-based morphometry using the RAVENS maps: methods and validation using simulated longitudinal atrophy. Neuroimage. 14: 1361-9. (Pubitemid 33124184)
9. Draganski B, Geisler P, Hajak G, Schuierer G, Bogdahn U, Winkler J, et al. (2002). Hypothalamic gray matter changes in narcoleptic patients. Nat Med. 8: 1186-8. (Pubitemid 35373535)
10. Fischl B, Salat DH, Busa E, et al. (2002). Whole brain segmentation: automated labeling of neuroanatomical structures in the human brain. Neuron. 33: 41-355.
11. Guilleminault C, Lee JH, Arias V (2007). Cataplexy. In: Bassetti C, Billiard M, Mignot E, editors. Narcolepsy and hypersomnia. New York: Informa p.49-62.
12. Gulyani S, Wu MF, Nienhuis R, John J, Siegel JM (2002). Cataplexy-related neurons in the amygdala of the narcoleptic dog. Neuroscience. 112: 355-65. (Pubitemid 34607019)
13. Hong SB, Tae WS, Joo EY (2006). Cerebral perfusion changes during cataplexy in narcolepsy patients. Neurology. 66: 1747-9. (Pubitemid 43964637)
14. Joo EY, Tae WS, Kim ST, Hong SB (2009). Gray matter concentration abnormality in brains of narcolepsy patients. Korean J Radiol. 10: 552-558.
15. Kaufmann C, Schuld A, Pollmacher T, Auer DP (2002). Reduced cortical gray matter in narcolepsy: preliminary findings with voxel-based morphometry. Neurology. 58: 1852-5. (Pubitemid 34663592)
16. Kennedy KM, Erickson KI, Rodrigue KM, Voss MW, Colcombe SJ, Kramer AF, et al. (2009). Age-related differences in regional brain volumes: a comparison of optimized voxel-based morphometry to manual volumetry. Neurobiol Aging. 30: 1657-76.
17. Khatami R, Birkmann S, Bassetti CL (2007). Amygdala dysfunction in narcolepsy-cataplexy. J Sleep Res. 16: 226-9. (Pubitemid 46850090)
18. Kim SJ, Lyoo IK, Lee YS, Lee JY, Yoon SJ, Kim JE, et al. (2009). Gray matter deficits in young adults with narcolepsy. Acta Neurol Scand. 119: 61-67.
19. Maquet P, Peters JM, Aerts J, Delfiore G, Degueldre C, Luxen A, et al. (1996). Functional neuroanatomy of human rapid-eye-movement sleep and dreaming. Nature. 383: 163-6. (Pubitemid 26303977)
20. Mignot E, Lammers GJ, Ripley B, Okun M, Nevsimalova S, Overeem S, et al. (2002). The role of cerebrospinal fluid hypocretin measurement in the diagnosis of narcolepsy and other hypersomnias. Arch Neurol. 59: 1553-62.
21. Mileykovskiy BY, Kiyashchenko LI, Siegel JM (2005). Behavioral correlates of activity in identified hypocretin/orexin neurons. Neuron. 46: 787-98. (Pubitemid 40733133)
22. Neto LL, Oliveira E, Correia F, Ferreira AG (2008). The human nucleus accumbens: Where is it? A stereotactic, anatomical and magnetic resonance imaging study. Neuromodulation. 11: 13-22.
23. Nishino S, Ripley B, Overeem S, Lammers GJ, Mignot E (2000). Hypocretin (orexin) deficiency in human narcolepsy. Lancet. 355: 39-40. (Pubitemid 30072183)
24. Overeem S, Mignot E, van Dijk JG, Lammers GJ (2001). Narcolepsy: clinical features, new pathophysiologic insights, and future perspectives. J Clin Neurophysiol. 18: 78-105. (Pubitemid 32549906)
25. Overeem S, Steens SC, Good CD, Ferrari MD, Mignot E, Frackowiak RS, et al. (2003). Voxel-based morphometry in hypocretin-deficient narcolepsy. Sleep. 26: 44-6.
26. Peyron C, Tighe DK, van den Pol AN, de Lecea L, Heller HC, Sutcliffe JG, et al. (1998). Neurons containing hypocretin (orexin) project to multiple neuronal systems. J Neurosci. 18: 9996-10015. (Pubitemid 28543775)
27. Poryazova R, Schnepf B, Werth E, Khatami R, Dydak U, Meier D, etal. (2009). Evidence for metabolic hypothalamo-amygdala dysfunction in narcolepsy. Sleep. 32: 607-13.
28. Rasova K, Krasensky J, Havrdova E, Obenberger J, Seidl Z, Dolezal O, et al. (2005). Is it possible to actively and purposely make use of plasticity and adaptability in the neurorehabilitation treatment of multiple sclerosis patients? A pilot project. Clin Rehabil. 19: 170-81. (Pubitemid 40309188)
29. Reiss AL, Hoeft F, Tenforde AS, Chen W, Mobbs D, Mignot EJ (2008). Anomalous hypothalamic responses to humor in cataplexy. PLoS ONE. 3: e2225.
30. Schwartz S, Ponz A, Poryazova R, Werth E, Boesiger P, Khatami R, et al. (2008). Abnormal activity in hypothalamus and amygdala during humour processing in human narcolepsy with cataplexy. Brain. 131: 514-22. (Pubitemid 351197605)
31. Senjem ML, Gunter JL, Shiung MM, Petersen RC, Jack CR Jr (2005). Comparison of different methodological implementations of voxel-based morphometry in neurodegenerative disease. Neuroimage. 26: 600-8. (Pubitemid 40723618)
32. Siegel JM, Nienhuis R, Gulyani S, Ouyang S, Wu MF, Mignot E, et al. (1999). Neuronal Degeneration in Canine Narcolepsy. J Neurosci. 19: 248-57. (Pubitemid 29028966)
33. Simón-Arceo K, Ramirez-Salado I, Calvo JM (2003). Long-lasting enhancement of rapid eye movement sleep and pontogeniculo-occipital waves by vasoactive intestinal peptide microinjection into the amygdala temporal lobe. Sleep. 26: 259-64. (Pubitemid 39610671)
34. Sonka K, Tafti M, Billiard M (1991). Narcolepsy and ageing. In Smirne S, Franceschi M, Ferini-Strambi L, editors. Sleep and ageing. Milano: Masson p. 181-6.
35. Thannickal TC, Moore RY, Nienhuis R, Ramanathan L, Gulyani S, Aldrich M, et al. (2000). Reduced number of hypocretin neurons in human narcolepsy. Neuron. 27: 469-74.